It’s showtime baby🤩. Do you want to know how AlveoliX makes the *quantum leap 🚀 * to *replace unneeded animal testing⁉️ Check it out! Special thanks to Julia SchwambornSRF – Schweizer Radio und Fernsehen, Neue Zürcher Zeitung for making such a complex and game-changing science topic accessible to the public. 🙏

💊 Do you know why the AXLung-on-Chip is a great alternative to simple in vitro models and animal research, and which opportunities offers in the field of personalized medicine?   💡 Find out the answer in this great infographic by Astrid Tomczak-Plewka, which narrows down the challenges of mimicking the lung micro-environment to 4 key steps (Problem,…

📈 The medical start-up scene is booming: more than 2000 healthcare companies are founded in Switzerland every year, many of them in the field of biotechnology and medical technology. 📰 Learn about AlveoliX’s success story and the impact of its innovative environment including the Sitem StartUp Club (SSC) and the Medtech Hub.

👀 Take a closer look at how the Biological Barriers and Drug Delivery group at Helmholtz-Institute for Pharmaceutical Research Saarland has built an advanced inhalation model by using the AXLung-on-Chip System.  💊 With their advanced in vitro model, combining the breathing function and air-liquid interface, they are reproducing the inhalation of therapeutic drugs in vitro in nearly…

🚀 Predicting human response accurately is the ultimate goal for medical research.📙 How can you achieve this? ▶️ Discover how AlveoliX Organs-on-Chip can help you to build a more relevant and physiological barrier model thanks to its nature-inspired integrated 3D stretch technology.

Despite the covid-19 crisis and no mega-rounds of investment in 2020, Biotech start-ups are back at the top!Swiss Biotech startups collected more than CHF 800 million in 2020, an increase of 31% compared to 2019. This is linked to the fact that innovation in drug development is taking place in the long term and, to…

Approximately 95% of drugs that are effective and safe in animal experiments fail in human clinical trials. This high failure rate is mostly explained by the fact that these tests are carried out in a different organism, and hence translation to humans is not straightforward. PETA has been committed for years to provide contrasted data…

Here is the team behind the scene! Big thanks to Innosuisse for their support and helping us bringing our chip one step closer to society. Check out the article and the video “Reproducing pulmonary function in the lab”

In an interview with WirtschaftsraumBern Magazine, Nina Hobi introduced our technology and vision to support animal replacement and shorten up the time required for drug development and approval. «Chaka Chaka & Waka Waka» is the magic advice from our CEOs for launching a start-up. Read the article “20 Bernese start-ups that you must know”